Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Ohio State University Comprehensive Cancer Center · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
recurrent malignant glioma, recurrent who grade 3 glioma, recurrent who grade 4 glioma, who grade 2 glioma, who grade 3 glioma, who grade 4 glioma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 891469
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.